Ekta Khattar

1.6k total citations
22 papers, 1.2k citations indexed

About

Ekta Khattar is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Ekta Khattar has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Physiology and 3 papers in Oncology. Recurrent topics in Ekta Khattar's work include Telomeres, Telomerase, and Senescence (13 papers), RNA Interference and Gene Delivery (6 papers) and DNA Repair Mechanisms (5 papers). Ekta Khattar is often cited by papers focused on Telomeres, Telomerase, and Senescence (13 papers), RNA Interference and Gene Delivery (6 papers) and DNA Repair Mechanisms (5 papers). Ekta Khattar collaborates with scholars based in India, Singapore and Australia. Ekta Khattar's co-authors include Vinay Tergaonkar, Vinay Tergaonkar, Shi Chi Leow, Shang Li, Semih Can Akıncılar, Vijay Kumar, Manoj Garg, Gouri Pandya, Anuradha Kirtonia and Gaye Saginc and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Ekta Khattar

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ekta Khattar India 13 736 492 211 176 133 22 1.2k
Semih Can Akıncılar Singapore 13 649 0.9× 424 0.9× 128 0.6× 151 0.9× 90 0.7× 16 1.1k
Jing Fang China 12 1.1k 1.4× 382 0.8× 588 2.8× 267 1.5× 103 0.8× 17 1.5k
Hisashi Hisatomi Japan 19 713 1.0× 350 0.7× 171 0.8× 122 0.7× 115 0.9× 62 1.2k
Ryan E. Henry United States 12 860 1.2× 285 0.6× 251 1.2× 256 1.5× 58 0.4× 16 1.4k
A. Pieter J. van den Heuvel United States 13 967 1.3× 159 0.3× 363 1.7× 335 1.9× 121 0.9× 14 1.4k
Ruth I. Tennen United States 8 646 0.9× 488 1.0× 215 1.0× 76 0.4× 44 0.3× 9 1.3k
Jing Niu China 18 641 0.9× 190 0.4× 90 0.4× 105 0.6× 53 0.4× 44 970
Manikandan Lakshmanan Singapore 15 835 1.1× 141 0.3× 198 0.9× 196 1.1× 64 0.5× 28 1.2k
Irit Zurer Israel 10 590 0.8× 150 0.3× 357 1.7× 228 1.3× 68 0.5× 11 951
J. E. Kravchenko Russia 10 1.0k 1.4× 130 0.3× 563 2.7× 356 2.0× 139 1.0× 17 1.5k

Countries citing papers authored by Ekta Khattar

Since Specialization
Citations

This map shows the geographic impact of Ekta Khattar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ekta Khattar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ekta Khattar more than expected).

Fields of papers citing papers by Ekta Khattar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ekta Khattar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ekta Khattar. The network helps show where Ekta Khattar may publish in the future.

Co-authorship network of co-authors of Ekta Khattar

This figure shows the co-authorship network connecting the top 25 collaborators of Ekta Khattar. A scholar is included among the top collaborators of Ekta Khattar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ekta Khattar. Ekta Khattar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khattar, Ekta, et al.. (2025). p53-deficient cancer cells hyperactivate DNA double-strand break repair pathways to overcome chemotherapeutic damage and augment survival. Molecular Biology Reports. 52(1). 333–333. 1 indexed citations
2.
Kirtonia, Anuradha, Gouri Pandya, Aishwarya Singh, et al.. (2025). Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modulation of miR-193b/KRAS/LAMC2/ERK/AKT signaling cascade. Life Sciences. 362. 123364–123364. 5 indexed citations
3.
Shah, Prachi, et al.. (2024). Role of p53 transcription factor in determining the efficacy of telomerase inhibitors in cancer treatment. Life Sciences. 339. 122416–122416. 7 indexed citations
5.
Khattar, Ekta, et al.. (2023). POT1 mutations cause differential effects on telomere length leading to opposing disease phenotypes. Journal of Cellular Physiology. 238(6). 1237–1255. 11 indexed citations
6.
Khattar, Ekta, et al.. (2023). Optimization of Performance Parameters of the TAGGG Telomere Length Assay. Journal of Visualized Experiments. 2 indexed citations
7.
Khattar, Ekta, et al.. (2022). Telomerase inhibitor MST-312 and quercetin synergistically inhibit cancer cell proliferation by promoting DNA damage. Translational Oncology. 27. 101569–101569. 16 indexed citations
8.
Khattar, Ekta, et al.. (2021). Long non-coding RNAs at work on telomeres: Functions and implications in cancer therapy. Cancer Letters. 502. 120–132. 25 indexed citations
9.
Khattar, Ekta, et al.. (2021). External environmental agents influence telomere length and telomerase activity by modulating internal cellular processes: Implications in human aging. Environmental Toxicology and Pharmacology. 85. 103633–103633. 26 indexed citations
10.
Khattar, Ekta & Vinay Tergaonkar. (2020). Role of Rap1 in DNA damage response: implications in stem cell homeostasis and cancer. Experimental Hematology. 90. 12–17. 11 indexed citations
11.
Kirtonia, Anuradha, Gouri Pandya, Amit Kumar Pandey, et al.. (2020). Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics. Seminars in Cancer Biology. 68. 258–278. 136 indexed citations
12.
Pandya, Gouri, Anuradha Kirtonia, Vinay Tergaonkar, et al.. (2020). Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential. Cancers. 12(7). 1901–1901. 44 indexed citations
13.
Khattar, Ekta. (2018). Telomere length maintenance mechanisms in cancer. SHILAP Revista de lepidopterología. 5(1). 22–22. 1 indexed citations
14.
Khattar, Ekta & Vinay Tergaonkar. (2017). Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC. Frontiers in Cell and Developmental Biology. 5. 1–1. 114 indexed citations
15.
Akıncılar, Semih Can, et al.. (2016). Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation. Cancer Discovery. 6(11). 1276–1291. 121 indexed citations
16.
Chan, J., Zheng‐Shan Chong, Haofei Wang, et al.. (2016). RNAi Reveals Phase-Specific Global Regulators of Human Somatic Cell Reprogramming. Cell Reports. 15(12). 2597–2607. 40 indexed citations
17.
Koh, Cheryl M., Ekta Khattar, Shi Chi Leow, et al.. (2015). Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity. Journal of Clinical Investigation. 125(5). 2109–2122. 126 indexed citations
18.
Khattar, Ekta, Atish Mukherji, & Vijay Kumar. (2012). Akt augments the oncogenic potential of the HBx protein of hepatitis B virus by phosphorylation. FEBS Journal. 279(7). 1220–1230. 30 indexed citations
19.
Ghosh, Arkasubhra, Gaye Saginc, Shi Chi Leow, et al.. (2012). Telomerase directly regulates NF-κB-dependent transcription. Nature Cell Biology. 14(12). 1270–1281. 303 indexed citations
20.
Khattar, Ekta & Vijay Kumar. (2009). Mitogenic Regulation of p271 Gene Is Mediated by AP-1 Transcription Factors. Journal of Biological Chemistry. 285(7). 4554–4561. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026